Mosaed Maryam, Pourfathollah Ali Akbar, Moghadam Mostafa, Jazayeri Mir Hadi, Safdarian Amir Reza
Iran Blood Transfusion Research Center, Tarbiat Modares University, Tehran, Iran.
Tarbiat Modares University, Iranian Blood Transfusion Organization, Tehran, Iran.
Asian J Transfus Sci. 2020 Jul-Dec;14(2):167-171. doi: 10.4103/ajts.AJTS_15_17. Epub 2020 Dec 19.
There are some antibodies which are present in healthy individuals without any former exposure to foreign antigens; they are known as natural autoantibodies (NAAbs). In recent years, it was shown that they probably contribute to the homeostasis of the whole body and might be present before beginning of some diseases. Thus, as new biomarkers, they are promising factors to diagnose diseases.
In this study, we drew upon samples of 924 individuals (600 controls and 324 cases) with underlying diseases of anemia, polycythemia, leukocytosis, thrombocytopenia, thrombocytosis, and pancytopenia. For detection of NAAbs against red blood cell, plasma samples were incubated with their own red cell suspension in 4°C for 18 h. Then, positive samples were evaluated for antibody screening and titration.
Fifty-two (8.6%) controls and 58 (17.9%) cases showed positive reaction (Pv < 0.001). The prevalence of positive antibody screens among auto-positive controls was 53% and 100% among cases; moreover, strength of antibody screen reaction had a mean rank of 22.5 in controls and a mean rank of 38.5 in cases (Pv < 0.001). A significant relation was also observed between ABO blood group and prevalence of NAAbs in controls but not in cases (Pv < 0.05).
The prevalence and potency of NAAbs increased along with hematological changes; moreover, the antibody reactions' pattern and titration showed significant differences between the two groups and these may be useful as biomarker for monitoring and prediction of some hematological diseases.
在健康个体中存在一些从未接触过外来抗原的抗体;它们被称为天然自身抗体(NAAbs)。近年来,研究表明它们可能有助于维持全身的内环境稳定,并且可能在某些疾病开始之前就已存在。因此,作为新的生物标志物,它们是诊断疾病的有前景的因素。
在本研究中,我们抽取了924名患有贫血、红细胞增多症、白细胞增多症、血小板减少症、血小板增多症和全血细胞减少症等基础疾病的个体样本(600名对照和324例病例)。为了检测针对红细胞的NAAbs,将血浆样本与自身红细胞悬液在4℃下孵育18小时。然后,对阳性样本进行抗体筛查和滴定评估。
52名(8.6%)对照和58名(17.9%)病例显示阳性反应(Pv<0.001)。自身阳性对照中抗体筛查阳性的患病率为53%,病例中为100%;此外,抗体筛查反应强度在对照中的平均秩次为22.5,病例中为38.5(Pv<0.001)。在对照中还观察到ABO血型与NAAbs患病率之间存在显著关系,但病例中未观察到(Pv<0.05)。
NAAbs的患病率和效力随着血液学变化而增加;此外,两组之间抗体反应模式和滴定显示出显著差异,这些可能作为监测和预测某些血液学疾病的生物标志物。